FGC
IBIO icon

Financial Gravity Companies’s iBio IBIO Stock Holding History

Financial Gravity Companies’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Buy
+2
New +$4 ﹤0.01% 999
2025
Q2 		$2 Buy
+2
New +$2 ﹤0.01% 984
2024
Q4 		$5 Hold
2
– – ﹤0.01% 961
2024
Q3 		$4 Buy
+2
New +$4 ﹤0.01% 668

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Financial Gravity Companies's IBIO Position: Q2 2026 in Review

Financial Gravity Companies opened a new position in iBio (IBIO) in Q2 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #999 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in IBIO as recently as Q2 2025.

Financial Gravity Companies first reported a position in IBIO in Q3 2024 and has held it in 4 quarters since. The position peaked at $5 in Q4 2024. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Financial Gravity Companies held 2 shares of iBio worth $4 as of Q2 2026.
  • iBio was a new Financial Gravity Companies position in Q2 2026.
  • iBio made up ﹤0.01% of Financial Gravity Companies's portfolio in Q2 2026, its #999 holding.
  • Financial Gravity Companies first reported a position in iBio in Q3 2024 and has held it in 4 quarters since.
  • Financial Gravity Companies's iBio position peaked at $5 in Q4 2024.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Financial Gravity Companies's 13F filing for Q2 2026, filed 5 Aug 2026.